D.E. Shaw & Co
ATOS icon

D.E. Shaw & Co’s Atossa Therapeutics ATOS Stock Holding History

D.E. Shaw & Co’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,435
Closed -$273K – 4245
2023
Q2 		$273K Sell
14,435
-40,456
-74% -$491K ﹤0.01% 3638
2023
Q1 		$597K Sell
54,891
-43,384
-44% -$484K ﹤0.01% 3466
2022
Q4 		$779K Sell
98,275
-19,547
-17% -$224K ﹤0.01% 3608
2022
Q3 		$1.47M Sell
117,822
-34,154
-22% -$496K ﹤0.01% 3279
2022
Q2 		$2.48M Sell
151,976
-105,566
-41% -$1.66M ﹤0.01% 2878
2022
Q1 		$4.83M Sell
257,542
-18,979
-7% -$386K ﹤0.01% 2354
2021
Q4 		$6.64M Buy
276,521
+216,784
+363% +$7.93M 0.01% 2080
2021
Q3 		$2.92M Buy
+59,737
New +$3.48M ﹤0.01% 2648

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return